Click on headlines below to download research

Clinical and commercial progress continues
NetScientific | 12/01/2018

In January Glycotest announced that it had completed a 149-person Chinese retrospective study of its test for hepatocellular carcinoma (HCC). It demonstrated…

Commercial progress across portfolio
NetScientific | 15/12/2017

Within the month of November 2017, NetScientific portfolio companies had a series of announcements reflecting increased adoption of their products. ProAxsis…

Progress continues
NetScientific | 11/10/2017

NetScientific’s healthcare portfolio progressed towards revenue generation during H117 with the soft launch of both Vortex and ProAxsis products…